# Surface Transforms: Major OEM 10 order, OEM 8 delay resolved

- Link: https://www.directorstalkinterviews.com/surface-transforms-major-oem-10-order-oem-8-delay-resolved/4121094864
- Published: 2022-12-16T07:19:57+00:00
- Author: Amilia Stone

**[Surface Transforms](https://www.directorstalkinterviews.com/company/surface-transforms-plc/sce.l)
plc** ([LON:SCE](https://www.directorstalkinterviews.com/company/surface-transforms-plc/sce.l))
The 24 November OEM 10 order raised the order book 50%. Even before this, it had
quadrupled in under two years. This latest £100m lifetime (six-year) order with 
OEM 10 is the second order from this US mega-OEM – a major cornerstone. The order
book is now £290m. SCE has visibility of the order inflow. It had stated, in the
autumn, that a new order would come before end-2022. A major milestone was achieved
this half-year, as SCE registered several profitable months. The production ramp-
up is very large, and the exciting growth at OEM 8 hit a pocket of air turbulence,
knocking that ramp-up a little, affecting 2022 profits, but not 2023.

 * **Order book up six-fold in under two years:** Three OEMs generate 2023E revenue,
   five in 2024E. End-sales of these models have waiting lists themselves, which
   adds visibility too. The models are mid- to upper-mid-market, and Surface Transforms
   now has minimal exposure at the super-car end, which reduces demand-risk.
 * **Growth ramp-up:** The growth ramp-up has now taken place. When many businesses
   are seeing gross margins fall, SCE has not; indeed, we upgrade our 2022 gross
   margin estimates. But a combination of OEM 8’s further rescheduling and capacity
   at its fullest pre-2023 expansion has meant a hit to 2022 profits.
 * **Numbers change:** 1H’22 sales were £2.9m, generating £2.5m losses. We cut our
   2H’22E sales of £9.6m to £3.6m. OEM 8’s order remains £100m, but start of production
   and ramp-up were delayed due to OEM 8 engineering issues. We raise our 2025E 
   sales and profits significantly. Earlier, we raised 2024E EPS by 38%.
 * **Risks:** SCE states: “The Company has also had its own production challenges,
   now materially rectified, and whilst they were neither the reason for the [OEM
   8] ramp up delay, nor the bulk of the sales shortfall, have limited the Company’s
   ability to build a finished stock buffer”. A new plant is scheduled to open in
   2H’23.
 * **Investment case:** Surface Transforms is rapidly growing its 10% market share
   in this fast-growth market. OEM 10 and OEM 8 have both placed several orders,
   and, while true “game changers”, these have simply fitted into the broader SCE
   place in the market expansion. 2H’22 saw OEM 9 arrive too. SCE delivers on a 
   global OEM base, margins are robust and production expansion is happening.

[DOWNLOAD THE FULL REPORT](https://hardmanandco.com/research/corporate-research/major-oem-10-order-oem-8-delay-resolved/?dm_i=49CL,1GK5C,6NAI95,6RFEA,1#report-download)

Share on:
